Croatia vs Czechia: HICP - Tea, mate and other plant-derived products for infusion (ND)
Croatia
1.72
in 2026
Czechia
1.49
in 2026
Croatia rank
5th
Czechia rank
8th
HICP - Tea, mate and other plant-derived products for infusion (ND) over time
- Croatia
- Czechia
How they compare
Croatia currently reports 1.72 against 1.49 in Czechia, a difference of 0.23.
That makes Croatia's figure about 1.2 times Czechia's.
The two have swapped places 5 times across 27 shared years of data; in 2000 it was Czechia ahead.
Croatia ranks 5th and Czechia ranks 8th of 27 countries.
Across the 3 decades both report, Croatia averaged higher in 2 and Czechia in 1.
Head to head by decade
| Decade | Croatia | Czechia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.26 | 2.06 | 0.803 | Czechia |
| 2010s | 2.32 | 1.98 | 0.335 | Croatia |
| 2020s | 1.84 | 1.83 | 0.0143 | Croatia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hicp - tea, mate and other plant-derived products for infusion (nd), Croatia or Czechia?
- Croatia, at 1.72 against 1.49 in Czechia as of 2026.
- What is the difference in hicp - tea, mate and other plant-derived products for infusion (nd) between Croatia and Czechia?
- 0.23, with Croatia ahead.
- How many years of comparable data are there for Croatia and Czechia?
- 27 years are reported by both, from 2000 to 2026.
- How do Croatia and Czechia rank globally for hicp - tea, mate and other plant-derived products for infusion (nd)?
- Croatia ranks 5th and Czechia ranks 8th of 27 countries.
- Where does this data come from?
- European Central Bank, published as HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight). Statizoid refreshes it automatically from the source and publishes the full history for both places.